Enanta Free Cash Flow Operating Cash Flow Ratio from 2010 to 2024

ENTA Stock  USD 13.91  0.35  2.58%   
Enanta Pharmaceuticals' Free Cash Flow Operating Cash Flow Ratio is decreasing over the years with stable fluctuation. Free Cash Flow Operating Cash Flow Ratio is expected to dwindle to 0.77. From 2010 to 2024 Enanta Pharmaceuticals Free Cash Flow Operating Cash Flow Ratio quarterly data regression line had arithmetic mean of  0.94 and r-squared of  0.02. View All Fundamentals
 
Free Cash Flow Operating Cash Flow Ratio  
First Reported
2010-12-31
Previous Quarter
0.98
Current Value
0.77
Quarterly Volatility
0.084427
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Enanta Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enanta main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 3.1 M or Selling General Administrative of 63.9 M, as well as many exotic indicators such as Price To Sales Ratio of 2.53, Dividend Yield of 0.0 or PTB Ratio of 1.92. Enanta financial statements analysis is a perfect complement when working with Enanta Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Enanta Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Enanta Pharmaceuticals Technical models . Check out the analysis of Enanta Pharmaceuticals Correlation against competitors.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.

Latest Enanta Pharmaceuticals' Free Cash Flow Operating Cash Flow Ratio Growth Pattern

Below is the plot of the Free Cash Flow Operating Cash Flow Ratio of Enanta Pharmaceuticals over the last few years. It is Enanta Pharmaceuticals' Free Cash Flow Operating Cash Flow Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enanta Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Operating Cash Flow Ratio10 Years Trend
Pretty Stable
   Free Cash Flow Operating Cash Flow Ratio   
       Timeline  

Enanta Free Cash Flow Operating Cash Flow Ratio Regression Statistics

Arithmetic Mean0.94
Geometric Mean0.94
Coefficient Of Variation8.94
Mean Deviation0.06
Median0.95
Standard Deviation0.08
Sample Variance0.01
Range0.3178
R-Value(0.13)
Mean Square Error0.01
R-Squared0.02
Significance0.63
Slope(0)
Total Sum of Squares0.1

Enanta Free Cash Flow Operating Cash Flow Ratio History

2024 0.77
2023 0.98
2022 1.09
2021 1.03
2020 1.01
2019 0.8
2018 0.92

About Enanta Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Enanta Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Enanta Pharmaceuticals investors use historical funamental indicators, such as Enanta Pharmaceuticals's Free Cash Flow Operating Cash Flow Ratio, to determine how well the company is positioned to perform in the future. Although Enanta Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Enanta Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Enanta Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Enanta Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Enanta Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Operating Cash Flow Ratio 0.98  0.77 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Enanta Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Enanta Pharmaceuticals' short interest history, or implied volatility extrapolated from Enanta Pharmaceuticals options trading.

Pair Trading with Enanta Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enanta Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Enanta Stock

  0.71VKTX Viking TherapeuticsPairCorr
  0.7DYAI Dyadic International Financial Report 8th of May 2024 PairCorr

Moving against Enanta Stock

  0.52OVID Ovid TherapeuticsPairCorr
  0.43LFCR Lifecore Biomedical Financial Report 6th of June 2024 PairCorr
  0.42ORGO Organogenesis Holdings Earnings Call This WeekPairCorr
  0.41GNLX Genelux CommonPairCorr
The ability to find closely correlated positions to Enanta Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enanta Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enanta Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enanta Pharmaceuticals to buy it.
The correlation of Enanta Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enanta Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enanta Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enanta Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:
Check out the analysis of Enanta Pharmaceuticals Correlation against competitors.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Enanta Stock analysis

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(6.57)
Revenue Per Share
3.5
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.23)
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.